Skip to main content
An official website of the United States government

Extramural vs Intramural and RMS Funding

The following is a comparison organized by mechanism and by the difference between total extramural dollars spent vs total intramural research program (IRP) and research management and support (RMS) dollars.

Download the Data

FY 2017-2025 Total NCI Funding
(Dollars in Millions)
2017*2018*2019*2020*2021*2022*2023*202420252017-2025 % Change
$5,636.4$5,927.7$5,992.3$6,383.4$6,442.7$6,833.7$7,186.8$7,240.9$7,219.85.2%
*Fiscal years 2023 through 2017 include Cancer MoonshotSM funding appropriated that fiscal year and exclude all carryover obligations for fiscal years 2023 through 2018.
FY 2017-2025 Extramural Funding
(Dollars in Millions)
Mechanism2017*2018*2019*2020*2021*2022*2023*202420252017-2025 % Change
Research Project Grants$2,278.4$2,450.6$2,541.7$2,749.4$2,822.4$2,966.5$3,145.2$3,129.8$3,122.66.0%
Cancer Centers313.0331.4337.1382.0344.7339.7353.5495.1607.14.1%
SPOREs111.4115.8110.7113.2119.6128.2124.1113.9119.3-3.2%
Other P50s/P20s1.30.07.47.93.313.25.35.35.4-59.8%
Other Specialized Centers135.6178.3200.8110.795.9106.0141.5137.6135.833.5%
Other Research Grants481.9537.9506.8548.1556.2624.8621.5606.4615.0-0.5%
NRSA77.682.487.096.493.091.190.389.980.6-0.9%
R&D Contracts880.4825.4768.1823.0812.2835.8899.1888.2748.77.6%
Buildings & Facilities30.018.018.030.030.030.030.030.030.00.0%
Total Extramural Funds$4,309.7$4,539.8$4,577.5$4,860.7$4,877.3$5,135.3$5,410.5$5,496.2$5,464.55.4%
*Fiscal years 2023 through 2017 include Cancer MoonshotSM funding appropriated that fiscal year and exclude all carryover obligations for fiscal years 2023 through 2018.
FY 2017-2025 Intramural and RMS Funding
(Dollars in Millions)
Mechanism2017*2018*2019*2020*2021*2022*2023*202420252017-2025% Change
Intramural Research$899.7$945.5$964.9$1,072.6$1,102.5$1,230.4$1,278.5$1,345.4$1,263.53.9%
RMS427.0442.4449.9450.0462.9468.0497.8399.3491.86.4%
Total IRP & RMS Funds$1,326.7$1,387.9$1,414.8$1,522.6$1,565.4$1,698.4$1,776.3$1,744.7$1,755.34.6%
*Fiscal years 2023 through 2017 include Cancer MoonshotSM funding appropriated that fiscal year and exclude all carryover obligations for fiscal years 2023 through 2018.
  • Updated:
Email